SB Investment Advisers (UK)’s Relay Therapeutics RLAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$278M	Hold	27,904,963	–	–	3.59%	3
2025 Q4	$236M	Hold	27,904,963	–	–	2.36%	5
2025 Q3	$146M	Hold	27,904,963	–	–	1.1%	5
2025 Q2	$96.6M	Hold	27,904,963	–	–	0.77%	6
2025 Q1	$73.1M	Hold	27,904,963	–	–	0.67%	8
2024 Q4	$115M	Hold	27,904,963	–	–	1.01%	8
2024 Q3	$198M	Hold	27,904,963	–	–	1.63%	7
2024 Q2	$182M	Hold	27,904,963	–	–	1.68%	6
2024 Q1	$232M	Hold	27,904,963	–	–	2.29%	6
2023 Q4	$307M	Hold	27,904,963	–	–	2.73%	6
2023 Q3	$235M	Hold	27,904,963	–	–	1.93%	6
2023 Q2	$350M	Hold	27,904,963	–	–	2.67%	7
2023 Q1	$460M	Hold	27,904,963	–	–	3.78%	5
2022 Q4	$417M	Hold	27,904,963	–	–	3.48%	6
2022 Q3	$624M	Hold	27,904,963	–	–	4.78%	4
2022 Q2	$467M	Hold	27,904,963	–	–	3.71%	6
2022 Q1	$835M	Hold	27,904,963	–	–	3.96%	6
2021 Q4	$857M	Hold	27,904,963	–	–	2.5%	8
2021 Q3	$880M	Hold	27,904,963	–	–	2.73%	6
2021 Q2	$1.02B	Hold	27,904,963	–	–	2%	9
2021 Q1	$965M	Hold	27,904,963	–	–	1.67%	7
2020 Q4	$1.16B	Hold	27,904,963	–	–	4.67%	4
2020 Q3	$1.19B	Buy	+27,904,963	New	+$1.06B	10.21%	3

Other funds holding RLAY